Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancerANDROULAKIS, N; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2012, Vol 106, Num 12, pp 1917-1925, issn 0007-0920, 9 p.Article

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancerDASKALAKI, A; AGELAKI, S; PERRAKI, M et al.British journal of cancer. 2009, Vol 101, Num 4, pp 589-597, issn 0007-0920, 9 p.Article

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursBOZIONELOU, V; VAMVAKAS, L; GEORGOULIAS, V et al.British journal of cancer. 2007, Vol 97, Num 1, pp 43-49, issn 0007-0920, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II studyKAKOLYRIS, S; PAPADAKIS, E; AGELAKI, S et al.Lung cancer. 2001, Vol 32, Num 2, pp 179-187, issn 0169-5002Article

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapyKAKOLYRIS, S; SOUGLAKOS, J; AGELAKI, S et al.Lung cancer. 2000, Vol 30, Num 3, pp 193-198, issn 0169-5002Article

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma : a multicentre phase I studyGIANNAKAKIS, T; ZIRAS, N; VLACHONIKOLIS, J et al.European journal of cancer (1990). 2000, Vol 36, Num 6, pp 742-747, issn 0959-8049Article

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancerXENIDIS, N; PERRAKI, M; GEORGOULIAS, V et al.British journal of cancer. 2013, Vol 108, Num 3, pp 549-556, issn 0007-0920, 8 p.Article

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapyPALLIS, A. G; AGELAKI, S; HATZIDAKI, D et al.Lung cancer. 2008, Vol 62, Num 3, pp 356-363, issn 0169-5002, 8 p.Article

A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumorsKARAMPEAZIS, A; VAMVAKAS, L; AGELAKI, S et al.Oncology. 2006, Vol 71, Num 5-6, pp 347-353, issn 0030-2414, 7 p.Article

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer : A phase II trialSOUGLAKOS, J; PALLIS, A; KAKOLYRIS, S et al.Oncology. 2005, Vol 69, Num 5, pp 384-390, issn 0030-2414, 7 p.Article

Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase ii studyALEXOPOULOS, A; KOUROUSSIS, C; RIGATOS, G et al.Annals of oncology. 2001, Vol 12, Num 6, pp 793-798, issn 0923-7534Article

Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor : A phase II study of the Greek Cooperative Group for Pancreatic CancerSTATHOPOULOS, G. P; MAVROUDIS, D; TSAVARIS, N et al.Annals of oncology. 2001, Vol 12, Num 1, pp 101-103, issn 0923-7534Article

A dose escalation study of weekly docetaxel in patients with advanced solid tumorsKOUROUSSIS, Ch; AGELAKI, S; GEORGOULIAS, V et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 6, pp 488-492, issn 0344-5704Article

First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancerKAKOLYRIS, S; SAMONIS, G; KOUKOURAKIS, M et al.American journal of clinical oncology. 1999, Vol 22, Num 3, pp 273-277, issn 0277-3732Article

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapySOUGLAKOS, J; KALYKAKI, A; TSETIS, D et al.Annals of oncology. 2007, Vol 18, Num 2, pp 305-310, issn 0923-7534, 6 p.Article

A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumorsKALYKAKI, A; VAMVAKAS, L; GEORGOULIAS, V et al.Oncology. 2006, Vol 71, Num 3-4, pp 197-203, issn 0030-2414, 7 p.Article

Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II studyMAVROUDIS, D; PAVLAKOU, G; MAGKANAS, E et al.Lung cancer. 2003, Vol 39, Num 1, pp 71-76, issn 0169-5002, 6 p.Article

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerSTATHOPOULOS, G. P; RIGATOS, S. K; STATHOPOULOS, J. G et al.Annals of oncology. 2003, Vol 14, Num 3, pp 388-394, issn 0923-7534, 7 p.Article

Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancerKOSMAS, C; AGELAKI, S; GIANNAKAKIS, Th et al.Oncology. 2002, Vol 62, Num 2, pp 103-109, issn 0030-2414Article

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: A multicenter phase II trialSOUGLAKOS, J; MAVROUDIS, D; SAMONIS, G et al.Journal of clinical oncology. 2002, Vol 20, Num 11, pp 2651-2657, issn 0732-183XArticle

Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II studyKAKOLYRIS, S; MAVROUDIS, D; TSAVARIS, N et al.Annals of oncology. 2001, Vol 12, Num 2, pp 193-197, issn 0923-7534Article

Front-line treatment of advanced breast cancer with docetaxel and epirubicin : A multicenter phase II studyMAVROUDIS, D; ALEXOPOULOS, A; RIGATOS, G et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1249-1254, issn 0923-7534Article

Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancerGEORGOULIAS, V; APOSTOLAKI, S; MAVROUDIS, D et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 6, pp 1217-1225, issn 0344-5704, 9 p.Article

A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancerAGELAKI, S; KONTOPODIS, E; KOTSAKIS, A et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 1, pp 45-51, issn 0344-5704, 7 p.Article